Vivos Therapeutics Stock Price on December 2, 2024
| VVOS Stock | USD 4.55 0.06 1.30% |
If you're considering investing in Vivos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vivos Therapeutics stands at 4.55, as last reported on the 10th of December, with the highest price reaching 4.78 and the lowest price hitting 4.42 during the day. Vivos Therapeutics appears to be dangerous, given 3 months investment horizon. Vivos Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11% return per unit of risk over the last 3 months. By inspecting Vivos Therapeutics' technical indicators, you can evaluate if the expected return of 0.93% is justified by implied risk. Please review Vivos Therapeutics' Coefficient Of Variation of 859.14, risk adjusted performance of 0.0932, and Semi Deviation of 5.25 to confirm if our risk estimates are consistent with your expectations.
At this time, Vivos Therapeutics' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Sale Purchase Of Stock is expected to grow at the current pace this year, whereas Common Stock Total Equity is likely to drop 1,566 in 2024. . At this time, Vivos Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.02 in 2024, whereas Price Earnings Ratio is likely to drop (1.17) in 2024. Vivos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Vivos |
Sharpe Ratio = 0.1131
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VVOS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.25 actual daily | 73 73% of assets are less volatile |
Expected Return
| 0.93 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Vivos Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vivos Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.6306 | Enterprise Value Ebitda (0.21) | Price Sales 1.5898 | Shares Float 3.1 M | Wall Street Target Price 6.3 |
Related Headline
Bone Biologics Headline on 2nd of December 2024
Bone Biologics Co. Short Interest Update by thelincolnianonline.com
Bone Biologics Co. was the recipient of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 58,200 shares, a decline of 19.3 percent from the October 31st total of 72,100 shares. Approximately 10.9 percent of the shares of the stock are
Vivos Therapeutics Valuation on December 2, 2024
It is possible to determine the worth of Vivos Therapeutics on a given historical date. On December 2, 2024 Vivos was worth 3.4 at the beginning of the trading date compared to the closed value of 3.66. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vivos Therapeutics stock. Still, in general, we apply an absolute valuation method to find Vivos Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vivos Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vivos Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.34 | 3.44 | 3.31 | 3.41 | 78,175 | |
12/02/2024 | 3.40 | 4.00 | 3.31 | 3.66 | 555,041 |
| 3.66 | 3.79 | 3.44 | 3.58 | 160,652 |
| Backtest Vivos Therapeutics | | | Vivos Therapeutics History | | | Vivos Therapeutics Valuation | Previous | Next |
Vivos Therapeutics Trading Date Momentum on December 2, 2024
| On December 03 2024 Vivos Therapeutics was traded for 3.58 at the closing time. The top price for the day was 3.79 and the lowest listed price was 3.44 . The trading volume for the day was 160.7 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 2.19% . The trading price change against the current closing price is 27.32% . |
Vivos Therapeutics Fundamentals Correlations and Trends
By evaluating Vivos Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vivos Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vivos financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vivos Therapeutics Stock history
Vivos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vivos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vivos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vivos Therapeutics stock prices may prove useful in developing a viable investing in Vivos Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.2 M | 899.6 K | |
| Net Loss | -18.3 M | -19.2 M |
Vivos Therapeutics Stock Technical Analysis
Vivos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vivos Therapeutics Period Price Range
Low | December 10, 2024
| High |
0.00 | 0.00 |
Vivos Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vivos Therapeutics December 10, 2024 Market Strength
Market strength indicators help investors to evaluate how Vivos Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vivos Therapeutics shares will generate the highest return on investment. By undertsting and applying Vivos Therapeutics stock market strength indicators, traders can identify Vivos Therapeutics entry and exit signals to maximize returns
Vivos Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vivos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vivos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vivos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0932 | |||
| Jensen Alpha | 0.9262 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.1273 | |||
| Treynor Ratio | 11.9 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.